INDV
Indivior Pharmaceuticals, Inc.Company with tickers: INDV
CIK
1625297
CUSIP
45579U109
Shares Outstanding
118,204,585
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $317,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | — | ||||
| Gross Profit | $277,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Expenses | $139,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Research & Development | — | ||||
| Operating Income | $137,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $89,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $0.71 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $0.69 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |